Andlauer Healthcare Group Inc.
ANDHF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $1 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $2 | $2 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -5.7% | -1.3% | 5.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 22.9% | 22.1% | 23.5% | 23.3% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 24.5% | 27.3% | 26% | 26.2% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 8.6% | 12.2% | 10.4% | 10.2% |
| EPS Diluted | 0.34 | 0.51 | 0.44 | 0.41 |
| % Growth | -33.3% | 15.9% | 7.3% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |